SVS Guidelines Bundle

Peripheral Arterial Disease

SVS GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/1309714

Contents of this Issue

Navigation

Page 11 of 11

106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies, at GuidelineCentral.com Copyright © 2016 All rights reserved SVSLE16052b Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It focuses on the needs of primary care practice, but also is applicable to providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Source Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, Moneta GL, Murad MH, Powell RJ, Reed AB, Schanzer A, Sidawy AN; Society for Vascular Surgery. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015;61(3 Suppl):2S-41S. Abbreviations ABI, ankle-brachial index; ACEI, Angiotensin-converting enzyme inhibitor; AIOD, aortoiliac occlusive disease; BMS, bare-metal stent; CFA, common femoral artery; CT, computed tomography; CTA, computed tomography angiography; MRA, magnetic resonance angiography; CV, cardiovascular; EVT, endovascular therapy; FPOD, femoropopliteal occlusive disease; IC, intermittent claudication; MI, myocardial infarction; PAD, peripheral arterial disease; SFA, superficial femoral artery Recommendation Grading Strength of Recommendation Level of Evidence 1 – Strong Benefit clearly outweighs risk A High 2 – Weak Benefits and risks are more closely matched and are more dependent on specific clinical scenarios B Moderate C Low U Ungraded

Articles in this issue

Links on this page

Archives of this issue

view archives of SVS Guidelines Bundle - Peripheral Arterial Disease